📰 Merck Sharp News
Page 121 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
November 4, 2021
The first pill for Covid-19 treatment, Molnupiravir made by MSD, has been approved for use in the UK by the MHRA.
November 4, 2021
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New Scientist and essential information about the covid-19 pandemic
November 4, 2021
It marks the first authorisation from a public health body for oral antiviral treatment for Covid.
November 4, 2021
It marks the first authorisation from a public health body for oral antiviral treatment for Covid.
November 4, 2021
The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19
November 4, 2021
Molnupiravir is safe and effective at reducing the risk of hospitalisation and death in mild to moderate COVID-19, the regulator said today.
November 4, 2021
The first pill for Covid-19 treatment, Molnupiravir made by MSD, has been approved for use in the UK by the MHRA.
November 4, 2021
The antiviral was found to be safe and effective following a stringent review of the available evidence.
November 4, 2021
The first pill for Covid-19 treatment, Molnupiravir made by MSD, has been approved for use in the UK by the MHRA.
November 4, 2021
The first pill for Covid-19 treatment, Molnupiravir made by MSD, has been approved for use in the UK by the MHRA.